.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Chinese Patent Office
Boehringer Ingelheim
Moodys
Accenture
Fuji
Dow
Colorcon
Express Scripts
Johnson and Johnson

Generated: November 17, 2017

DrugPatentWatch Database Preview

Zidovudine - Generic Drug Details

« Back to Dashboard

What are the generic sources for zidovudine and what is the scope of zidovudine freedom to operate?

Zidovudine
is the generic ingredient in two branded drugs marketed by Viiv Hlthcare, Mylan Pharms Inc, Ranbaxy Labs Ltd, Aurobindo Pharma Ltd, Matrix Labs Ltd, Liaoning Chengda, West-ward Pharms Int, Cipla Ltd, Luitpold, Hec Pharm Usa Inc, Cipla, Aurobindo, Hetero Labs Ltd Iii, and Aurobindo Pharma, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for zidovudine. Sixteen suppliers are listed for this compound. There is one tentative approval for this compound.

Tentative approvals for ZIDOVUDINE

Applicant Application No. Strength Dosage Form
u► Subscribe100MGCAPSULE; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
ZIDOVUDINE
zidovudine
TABLET;ORAL076844-001Sep 19, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma
ZIDOVUDINE
zidovudine
TABLET;ORAL022294-001Jul 23, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy Labs Ltd
ZIDOVUDINE
zidovudine
TABLET;ORAL077327-001Sep 19, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Viiv Hlthcare
RETROVIR
zidovudine
SYRUP;ORAL019910-001Sep 28, 1989AARXYesYes► Subscribe► Subscribe► Subscribe
Cipla Ltd
ZIDOVUDINE
zidovudine
CAPSULE;ORAL078349-001May 23, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo
ZIDOVUDINE
zidovudine
SYRUP;ORAL077268-001Sep 19, 2005AARXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo
ZIDOVUDINE
zidovudine
TABLET;ORAL077267-001Sep 19, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Viiv Hlthcare
RETROVIR
zidovudine
CAPSULE;ORAL019655-001Mar 19, 1987ABRXYesYes► Subscribe► Subscribe► Subscribe
Viiv Hlthcare
RETROVIR
zidovudine
INJECTABLE;INJECTION019951-001Feb 2, 1990APRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ZIDOVUDINE
zidovudine
TABLET;ORAL078922-001Feb 14, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: zidovudine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viiv Hlthcare
RETROVIR
zidovudine
TABLET;ORAL020518-001Dec 19, 1995► Subscribe► Subscribe
Viiv Hlthcare
RETROVIR
zidovudine
CAPSULE;ORAL019655-001Mar 19, 1987► Subscribe► Subscribe
Viiv Hlthcare
RETROVIR
zidovudine
INJECTABLE;INJECTION019951-001Feb 2, 1990► Subscribe► Subscribe
Viiv Hlthcare
RETROVIR
zidovudine
SYRUP;ORAL019910-001Sep 28, 1989► Subscribe► Subscribe
Viiv Hlthcare
RETROVIR
zidovudine
CAPSULE;ORAL019655-001Mar 19, 1987► Subscribe► Subscribe
Viiv Hlthcare
RETROVIR
zidovudine
SYRUP;ORAL019910-001Sep 28, 1989► Subscribe► Subscribe
Viiv Hlthcare
RETROVIR
zidovudine
INJECTABLE;INJECTION019951-001Feb 2, 1990► Subscribe► Subscribe
Viiv Hlthcare
RETROVIR
zidovudine
TABLET;ORAL020518-002Oct 4, 1996► Subscribe► Subscribe
Viiv Hlthcare
RETROVIR
zidovudine
CAPSULE;ORAL019655-001Mar 19, 1987► Subscribe► Subscribe
Viiv Hlthcare
RETROVIR
zidovudine
TABLET;ORAL020518-002Oct 4, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Harvard Business School
Deloitte
Merck
QuintilesIMS
Chinese Patent Office
Cerilliant
Express Scripts
Argus Health
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot